These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 25356056)

  • 1. Therapeutic effects of globular adiponectin in diabetic rats with nonalcoholic fatty liver disease.
    Ma H; Cui F; Dong JJ; You GP; Yang XJ; Lu HD; Huang YL
    World J Gastroenterol; 2014 Oct; 20(40):14950-7. PubMed ID: 25356056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel role of globular adiponectin in treatment with HFD/STZ induced T2DM combined with NAFLD rats.
    Ma H; You GP; Zhang XP; Yang XJ; Lu HD; Huang YL; Zhang WQ
    ScientificWorldJournal; 2014; 2014():230835. PubMed ID: 24683323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tangganjian decoction ameliorates type 2 diabetes mellitus and nonalcoholic fatty liver disease in rats by activating the IRS/PI3K/AKT signaling pathway.
    Fan Y; He Z; Wang W; Li J; Hu A; Li L; Yan L; Li Z; Yin Q
    Biomed Pharmacother; 2018 Oct; 106():733-737. PubMed ID: 29990865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving hepatic mitochondrial biogenesis as a postulated mechanism for the antidiabetic effect of Spirulina platensis in comparison with metformin.
    Oriquat GA; Ali MA; Mahmoud SA; Eid RMHM; Hassan R; Kamel MA
    Appl Physiol Nutr Metab; 2019 Apr; 44(4):357-364. PubMed ID: 30208279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Liuwei Dihuang decoction on PI3K/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance.
    Dai B; Wu Q; Zeng C; Zhang J; Cao L; Xiao Z; Yang M
    J Ethnopharmacol; 2016 Nov; 192():382-389. PubMed ID: 27401286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mori Cortex extract ameliorates nonalcoholic fatty liver disease (NAFLD) and insulin resistance in high-fat-diet/streptozotocin-induced type 2 diabetes in rats.
    Ma LL; Yuan YY; Zhao M; Zhou XR; Jehangir T; Wang FY; Xi Y; Bu SZ
    Chin J Nat Med; 2018 Jun; 16(6):411-417. PubMed ID: 30047462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eugenosedin-A improves glucose metabolism and inhibits MAPKs expression in streptozotocin/nicotinamide-induced diabetic rats.
    Shen KP; Lin HL; Yen HW; Hsieh SL; An LM; Wu BN
    Kaohsiung J Med Sci; 2018 Mar; 34(3):142-149. PubMed ID: 29475461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigallocatechin-3-gallate ameliorates glucolipid metabolism and oxidative stress in type 2 diabetic rats.
    Li W; Zhu C; Liu T; Zhang W; Liu X; Li P; Zhu T
    Diab Vasc Dis Res; 2020; 17(6):1479164120966998. PubMed ID: 33280417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective Effects of Chaihu Shugan San () on Nonalcoholic Fatty Liver Disease in Rats with Insulin Resistance.
    Jiang WN; Li D; Jiang T; Guo J; Chen YF; Wang J; Zhou Y; Yang CY; Tang CP
    Chin J Integr Med; 2018 Feb; 24(2):125-132. PubMed ID: 27164963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats.
    He Q; Li JK; Li F; Li RG; Zhan GQ; Li G; Du WX; Tan HB
    World J Gastroenterol; 2015 Feb; 21(7):2058-66. PubMed ID: 25717238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways.
    Luo Y; Yang P; Li Z; Luo Y; Shen J; Li R; Zheng H; Liang Y; Xia N
    Drug Des Devel Ther; 2019; 13():4065-4074. PubMed ID: 31819375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats.
    Polce SA; Burke C; França LM; Kramer B; de Andrade Paes AM; Carrillo-Sepulveda MA
    Nutrients; 2018 Apr; 10(5):. PubMed ID: 29693586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Obscure Effect of
    Misiakiewicz-Has K; Maciejewska-Markiewicz D; Rzeszotek S; Pilutin A; Kolasa A; Szumilas P; Stachowska E; Wiszniewska B
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Zuogui Jiangtang Qinggan Formula improves glucolipid metabolism in type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease by regulating FoxO1/MTP/APOB signaling pathway].
    Xiang YX; Huang YL; Zhou M; Zou JJ; Liu X; Liu ZY; Xiao F; Yu R; Xiang Q
    Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4438-4445. PubMed ID: 37802870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.
    Qiu X; Gao DH; Xiang X; Xiong YF; Zhu TS; Liu LG; Sun XF; Hao LP
    World J Gastroenterol; 2015 Jul; 21(26):8061-72. PubMed ID: 26185377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.
    Dwivedi DK; Jena GB
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):705-716. PubMed ID: 31834465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-21 antagomir improves insulin resistance and lipid metabolism disorder in streptozotocin-induced type 2 diabetes mellitus rats.
    Wang Y; Yang LZ; Yang DG; Zhang QY; Deng ZN; Wang K; Mao XJ
    Ann Palliat Med; 2020 Mar; 9(2):394-404. PubMed ID: 32233625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of TangGanJian on nonalcoholic fatty liver disease with type 2 diabetes mellitus.
    Fan Y; Xiong W; Li J; Hu A; He Z; Zhang J; Zhou G; Yin Q
    Pharm Biol; 2018 Dec; 56(1):567-572. PubMed ID: 30460863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of calycosin against high-fat diet-induced nonalcoholic fatty liver disease in mice.
    Duan X; Meng Q; Wang C; Liu Z; Sun H; Huo X; Sun P; Ma X; Peng J; Liu K
    J Gastroenterol Hepatol; 2018 Feb; 33(2):533-542. PubMed ID: 28699662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.